Carmignac Gestion Qiagen N.V. Transaction History

Carmignac Gestion

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2019 Aug 13, 2019	SELL	$35.73 - $41.39 $2.87 Million - $3.32 Million	-80,191 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$33.78 - $40.68 $7.12 Million - $8.58 Million	-210,841 Reduced 72.45%	80,191 $3.26 Million
Q4 2018 Feb 13, 2019	SELL	$32.65 - $37.95 $37.5 Million - $43.6 Million	-1,147,988 Reduced 79.78%	291,032 $10 Million
Q3 2018 Nov 13, 2018	SELL	$35.99 - $39.39 $34.4 Million - $37.6 Million	-955,211 Reduced 39.9%	1,439,020 $54.5 Million
Q2 2018 Aug 13, 2018	BUY	$31.23 - $37.47 $21.1 Million - $25.3 Million	674,940 Added 39.26%	2,394,231 $86.6 Million
Q1 2018 May 14, 2018	BUY	$31.01 - $34.72 $9.23 Million - $10.3 Million	297,779 Added 20.95%	1,719,291 $55.6 Million
Q4 2017 Feb 13, 2018	BUY	$30.68 - $35.37 $43.6 Million - $50.3 Million	1,421,512	1,421,512 $44 Million

6.37M

Ticker QGEN
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 227,694,000
Market Cap $10.4B
Description
QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...

Get notified when there are updates to the investment portfolio of Carmignac Gestion, based on Form 13F filings with the SEC.

Stay updated on Carmignac Gestion with notifications on news.